DIA422.81-7.68 -1.78%
SPX5,976.97-68.29 -1.13%
IXIC19,406.83-255.66 -1.30%

12 Health Care Stocks Moving In Thursday's Intraday Session

Benzinga·06/12/2025 17:06:14
Listen to the news

Gainers

  • Healthcare Triangle (NASDAQ:HCTI) shares moved upwards by 270.6% to $0.03 during Thursday's regular session. The company's market cap stands at $13.9 million.
  • Liminatus Pharma (NASDAQ:LIMN) shares moved upwards by 51.3% to $16.81. The market value of their outstanding shares is at $437.3 million.
  • Klotho Neurosciences (NASDAQ:KLTO) shares moved upwards by 42.76% to $2.07. The company's market cap stands at $67.2 million.
  • Reshape Lifesciences (NASDAQ:RSLS) stock moved upwards by 34.49% to $3.08. The company's market cap stands at $2.2 million.
  • Sagimet Biosciences (NASDAQ:SGMT) shares increased by 30.69% to $8.09. The company's market cap stands at $260.4 million.
  • Polyrizon (NASDAQ:PLRZ) shares moved upwards by 30.06% to $1.04. The company's market cap stands at $5.5 million.

Losers

  • Intensity Therapeutics (NASDAQ:INTS) stock fell 45.1% to $0.32 during Thursday's regular session. The market value of their outstanding shares is at $5.8 million.
  • Helius Medical Tech (NASDAQ:HSDT) stock declined by 44.14% to $0.62.
  • Shuttle Pharmaceuticals (NASDAQ:SHPH) shares declined by 33.35% to $0.15. The company's market cap stands at $1.6 million.
  • Jupiter Neurosciences (NASDAQ:JUNS) stock declined by 33.17% to $1.33. The company's market cap stands at $44.0 million.
  • Catheter Precision (AMEX:VTAK) shares declined by 27.83% to $0.43. The company's market cap stands at $4.7 million.
  • Simulations Plus (NASDAQ:SLP) shares decreased by 22.28% to $20.55. The market value of their outstanding shares is at $413.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit:  https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2025 Webull Securities Limited. All rights reserved.